Progressive deterioration of frailty is associated with poor outcomes in patients with transthyretin cardiac amyloidosis
Geriatr Gerontol Int
.
2021 Oct;21(10):967-969.
doi: 10.1111/ggi.14268.
Epub 2021 Aug 24.
Authors
Makoto Takahashi
1
,
Nao Okamoto
1
,
Koji Nishida
1
,
Yoko Nakaoka
1
,
Ryu-Ichiro Imai
1
,
Shu-Ichi Seki
1
,
Toru Kubo
2
,
Naohito Yamasaki
2
,
Hiroaki Kitaoka
2
,
Sho-Ichi Kubokawa
1
,
Kazuya Kawai
1
,
Naohisa Hamashige
1
,
Yoshinori Doi
1
3
Affiliations
1
Department of Medicine and Cardiology, Chikamori Hospital, Kochi, Japan.
2
Department of Cardiology and Aging Science, Kochi Medial School, Nankoku, Japan.
3
Cardiomyopathy Institute, Chikamori Hospital, Kochi, Japan.
PMID:
34427979
DOI:
10.1111/ggi.14268
No abstract available
Publication types
Letter
MeSH terms
Amyloidosis*
Frailty*
Humans
Prealbumin / genetics
Substances
Prealbumin